Multiple Sclerosis: New Program, New Treatments

Print icon

Each week, an estimated 200 Americans are diagnosed with multiple sclerosis (MS). But new treatments bring new hope, according to neuro-immunologist Dr. Brian Wong. He is helping to launch a comprehensive multiple sclerosis program at Hartford HealthCare’s Ayer Neuroscience Institute.

Q: What is neuro-immunology?

A: Neuro-immunology is a subspecialty of neurology. It focuses on the immune system’s role in contributing to neurologic diseases. This includes relatively common conditions like multiple sclerosis, as well as less common conditions, such as neuromyelitis optica and neuro-sarcoidosis.

Q: Tell us about the program you are creating at Hartford HealthCare. 

A: Our goal is to first properly diagnose patients with these conditions at our clinic in Southington. Once a diagnosis is made, we can provide an individualized treatment plan to minimize the effect that diseases like multiple sclerosis have on our patients’ lives.

Q: What type of treatments will be offered to patients?

A: There are currently 15 different medications approved for the treatment of multiple sclerosis. These medications help to prevent episodes of acute worsening, often called relapses, and consequently help minimize long term disability.  We are seeing very positive outcomes with these treatments and therefore selecting an appropriate medication for each individual is important.

Q: What do you want patients to know about multiple sclerosis and this new program?

A: It is a very exciting time in the field of neurology. For patients with multiple sclerosis, we have treatments which were not available to us in years past.  We are now able to achieve remarkable long term outcomes that simply were not possible before.

Learn more here about the multiple sclerosis services provided by the Hartford HealthCare Ayer Neuroscience Institute


What's New

Dr. Khalid M. Abbed

Renowned Spine Care Neurosurgeon joins Hartford HealthCare in Southwestern Connecticut

BRIDGEPORT —Hartford HealthCare announces the appointment of Dr. Khalid M. Abbed, one of New England’s leading neurosurgeons, as Co-Physician-in-Chief of its Ayer Neuroscience Institute. An experienced neurosurgeon and hospital director with a demonstrated history of leadership in the healthcare industry, he will oversee neurosurgical services and lead the Ayer Neuroscience...


HHC Neurology Services expand to Thomaston

The Hartford HealthCare Ayer Neuroscience Institute at Charlotte Hungerford Hospital has recently welcomed Nabi Chowdhury, MD, who is now accepting patients one day a week at the new CHH Specialty Care office located at 76 Watertown Road, Thomaston. The practice offers neurological evaluations, diagnosis and treatment of diseases and disorders...

Epilepsy

How Specialty Care Can Lower Risk of Death From Epilepsy

Patients getting epilepsy care in a specialty center had a lower chance of death, according to a Canadian study released in the Journal of the American Medical Society Neurology. Dr. Gabriel Martz, director of The Epilepsy Center at Hartford HealthCare’s Ayer Neuroscience Institute, said in some cases the challenges of...

Dr. Elena Bortan

Movement Disorders Care Comes to Mystic

Much as the design of the new Hartford HealthCare facility at 100 Perkins Farms Drive in Mystic reflects the vibe of coastal community, the location of specialists from the HHC Ayer Neuroscience Institute’s Chase Family Movement Disorders Center to the facility answers a demand for high-quality care and support in...

Ozzy Osbourne

How Physical Therapy Might Help Ozzy Osbourne, Other Parkinson’s Patients

For years, substance abuse might have been the presumed root of shaking and stumbling by rock star Ozzy Osbourne, but the 71-year-old rocker recently revealed that Parkinson’s disease is to blame. Parkinson’s, a chronic and progressive movement disorder for which there is treatment but no cure, affects more than 200,000...